Colorectal cancer metastatic and Gastrointestinal inflammation
Summary:
Gastrointestinal inflammation is found among people with Colorectal cancer metastatic, especially for people who are male, 60+ old.
The study analyzes which people have Gastrointestinal inflammation with Colorectal cancer metastatic. It is created by eHealthMe based on reports of 39 people who have Colorectal cancer metastatic from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
39 people who have Colorectal Cancer Metastatic and Gastrointestinal Inflammation are studied.
What is Colorectal cancer metastatic?
Colorectal cancer metastatic (cancer of colon and rectal spreads to other parts) is found to be associated with 324 drugs and 177 conditions by eHealthMe.
What is Gastrointestinal inflammation?
Gastrointestinal inflammation (inflammation of stomach and intestine) is found to be associated with 774 drugs and 512 conditions by eHealthMe.
Number of Gastrointestinal inflammation in Colorectal cancer metastatic reports submitted per year:

Gender of people who have Colorectal Cancer Metastatic and experienced Gastrointestinal Inflammation *:
- female: 23.68 %
- male: 76.32 %
Age of people who have Colorectal Cancer Metastatic and experienced Gastrointestinal Inflammation *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 2.7 %
- 50-59: 8.11 %
- 60+: 89.19 %
Common co-existing conditions for these people *:
- Rhinorrhea (watery mucus discharge from the nose): 12 people, 30.77%
- Acne (skin problems that cause pimples): 1 person, 2.56%
Common drugs taken by these people *:
- Xanax: 20 people, 51.28%
- Imodium: 20 people, 51.28%
- Avastin: 5 people, 12.82%
- Neulasta: 4 people, 10.26%
- Fluorouracil: 4 people, 10.26%
- Movicol: 4 people, 10.26%
- Lasix: 4 people, 10.26%
- Oxaliplatin: 3 people, 7.69%
- Mitomycin: 3 people, 7.69%
- Solu-Medrol: 3 people, 7.69%
Common symptoms for these people *:
- Diarrhea: 21 people, 53.85%
- Endocarditis (inflammation in heart muscle): 20 people, 51.28%
- Hypotension (abnormally low blood pressure): 19 people, 48.72%
- Fatigue (feeling of tiredness): 18 people, 46.15%
- Nausea (feeling of having an urge to vomit): 18 people, 46.15%
- Weight Decreased: 18 people, 46.15%
- Hair Loss: 17 people, 43.59%
- Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 17 people, 43.59%
- Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 17 people, 43.59%
- Oedema Peripheral (superficial swelling): 17 people, 43.59%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Gastrointestinal inflammation?
Check whether Gastrointestinal inflammation is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Schwerd T, Pandey S, Yang HT, Bagola K, Jameson E, Jung J, Lachmann RH, Shah N, Patel SY, Booth C, Runz H, "Impaired antibacterial autophagy links granulomatous intestinal inflammation in Niemann–Pick disease type C1 and XIAP deficiency with NOD2 variants in Crohn9s disease", Gut, 2016 Mar .
Related studies
Treatments, associated drugs and conditions:
- Colorectal cancer metastatic (21,899 reports)
- Gastrointestinal inflammation (7,706 reports)
COVID vaccines that are related to Gastrointestinal inflammation:
- Gastrointestinal inflammation in Moderna COVID Vaccine
- Gastrointestinal inflammation in Pfizer BioNTech Covid Vaccine
- Gastrointestinal inflammation in Johnson and Johnson Covid Vaccine
Common drugs associated with Gastrointestinal inflammation:
- Amlodipine: 113 reports
- Aspirin: 187 reports
- Calcium: 154 reports
- Cyclophosphamide: 139 reports
- Enbrel: 126 reports
- Humira: 2,862 reports
- Ibu: 118 reports
- Ibuprofen: 125 reports
- Imuran: 166 reports
- Metformin: 113 reports
- Methotrexate: 461 reports
- Morphine: 111 reports
- Nexium: 143 reports
- Omeprazole: 285 reports
- Pantoprazole: 207 reports
- Pentasa: 133 reports
- Prednisone: 611 reports
- Remicade: 268 reports
- Synthroid: 127 reports
- Tramadol: 104 reports
- Tylenol: 121 reports
- Vitamin b12: 142 reports
- Vitamin d: 213 reports
All the drugs that are associated with Gastrointestinal inflammation:
- Gastrointestinal inflammation (774 drugs)
Common conditions associated with Gastrointestinal inflammation:
- Ankylosing spondylitis: 101 reports
- Blood pressure increased: 331 reports
- Crohn's disease: 2,949 reports
- Crohns disease: 2,655 reports
- Feeling uptight: 108 reports
- Gastroesophageal reflux disease: 144 reports
- Hbp: 350 reports
- High blood cholesterol: 123 reports
- High blood pressure: 350 reports
- Hyperlipidemia: 123 reports
- Hypertension: 350 reports
- Ileitis: 2,655 reports
- Inflammatory bowel disease - crohn's disease: 2,655 reports
- Lipid test: 130 reports
- Lipoprotein test: 123 reports
- Multiple sclerosis: 115 reports
- Pain: 224 reports
- Pain management: 224 reports
- Psoriatic arthropathy aggravated: 126 reports
- Rheumatoid arthritis: 327 reports
- Stress and anxiety: 108 reports
- Uc: 527 reports
- Ulcerative colitis: 527 reports
All the conditions that are associated with Gastrointestinal inflammation:
- Gastrointestinal inflammation (512 conditions)
How the study uses the data?
The study is based on Gastrointestinal inflammation and Colorectal cancer metastatic, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Butabarb and Tylenol drug interaction - now
- Lialda and Hepatocellular Carcinoma - 2 seconds ago
- Benzonatate and Respiratory - 10 seconds ago
- Vaniqa and Conjunctivitis - 18 seconds ago
- Ambien Cr and Inflammation - 19 seconds ago
- Enbrel and Antibiotic Therapy - 22 seconds ago
- Simvastatin and Tumor Thrombosis - 22 seconds ago
- Bupropion Hydrobromide and Maternal Exposure During Pregnancy - 22 seconds ago
- Staphylococcal Infection and Toothaches - 23 seconds ago
- Serevent and Norplant drug interaction - 25 seconds ago